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Abstract
Background: Recent systematic reviews and editorials suggest that many organizations that produce nutritional
guideline recommendations do not adhere to internationally recognized standards set forth by the Institute of
Medicine (IoM), Guidelines International Network (GIN), Appraisal of Guidelines Research and Evaluation (AGREE),
and Grading Recommendations, Assessment, Development and Evaluation (GRADE).
Methods: The potential solution is an independent group with content expertise and skilled in the methodology
of systematic reviews and practice guidelines to produce trustworthy guideline recommendations,
recommendations that are supported by publication in a top tier journal. The BMJ Rapid Recommendations project
has recently demonstrated the feasibility and utility of this approach. Here, we are proposing trustworthy nutritional
guideline recommendations based on internationally accepted guideline development standards,
recommendations that will be informed by rigorous and novel systematic reviews of the benefits
and harms associated with nutritional exposures, as well as studies on the values and preferences related to dietary
behaviors among members of the international community.
Discussion: Adhering to international guideline standards, conducting high quality systematic reviews, and actively
assessing the values and preferences of key stakeholders is expected to improve the quality of nutritional guidelines
and their relevance to end-users, particularly patients and community members. We will send our work for peer
review, and if found acceptable, we will publish our nutritional recommendations in top-tier general medicine
journals.
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Background
Burden of disease and evidence-based care
Globally, chronic non-communicable illnesses represent
the largest burden of disease, and healthy eating habits
may be a cornerstone to the prevention and manage-
ment of chronic disease [1, 2]. Evidence suggests that
risk factors related to nutrition have a major impact on
disability adjusted life years (DALYs) and death. In the
US, estimates suggest that 14% of DALYs and 26% of
deaths are attributable to dietary risk factors [3]. Of the
20 leading risk factors for disability in 2010, 13 were
directly or indirectly related to diet, including high blood
pressure, body-mass index, fasting glucose, and low
consumption of fruits and vegetables [4]. The greatest
relative burden from chronic diseases such as diabetes,
heart disease and cancer may result from or may be
exacerbated by poor nutrition [5].
Despite the evidence that nutrition may play a major
role in curbing the burden of chronic disease, clinicians
typically do not emphasize nutrition in their interactions
with patients [6]. The knowledge and time required to
apply nutritional counseling in clinical practice comes
with a unique set of challenges, including a lack of suffi-
cient nutrition training in medical school and residency
programs, and a dearth of both time and financial com-
pensation for offering counseling [7]. Intense media cover-
age on what is often times low quality, non-systematic
collection of evidence (e.g. ecological observations, small
clinical studies based on biomarkers) in the field of nutri-
tion serves to compound the problem with a constant
source of conflicting messages [8].
Clinicians, including registered dietitians, require pri-
mary research and systematic evidence synthesis, includ-
ing meta-analyses, to understand the available evidence;
nutrition practice guidelines to provide appropriate in-
terpretation of evidence and direction in its application;
and user-friendly presentations and access to facilitate
efficient uptake. Systematic syntheses of evidence are
often, however, not available, or the syntheses that do
exist are of limited rigor. For example, in systematic re-
views and nutrition practice guidelines, important health
outcomes (i.e. end points most important to patients
and community members, such as mortality, quality of
life or dietary satisfaction) are often not optimally identi-
fied and synthesized, thus limiting our understanding of
the impact of interventions on patient and community
members’ lives [9].
Evidence-based nutrition involves the integration of the
best available evidence summaries, clinical and public
health practice experience, and patient and community
values and preferences [10, 11] (Johnston BC et al. The
Philosophy of Evidence-Based Principles and Practice in
Nutrition. Mayo Clinic Proceedings (submitted August
2018). Within this framework, clinicians can provide
optimal care and, when appropriate and possible, engage
in shared decision-making with patients, families and
members of the community to help them prevent, resolve
or cope with their physical, mental, and social health
problems.
The need for trustworthy nutrition guidelines
International groups, including the Institute of Medicine
(IoM), Appraisal of Guidelines Research and Evaluation
(AGREE), the Grading Recommendations, Assessment,
Development and Evaluation (GRADE) working group
[12–16], and the Guidelines International Network (GIN)
have, using consensus methods, developed recognized and
accepted guideline standards. All these standards promote
establishing evidence foundations based on systematic
reviews and subsequently using these systematic reviews
to contribute to ratings of the strength of recommenda-
tions [12, 15]. Systematic reviews can offer high or low
quality evidence and in either case guideline recommen-
dations can be weak or strong. Table 1 summarizes the
IoM standards for trustworthy guidelines.
Despite these widely accepted standards for trustworthy
guidelines and vastly improved methods and processes for
their production, systematic surveys of over 1100 practice
guidelines across a wide range of health topics indicate
that guidelines continue to suffer from important limita-
tions [17–19]. An evaluation of 626 guidelines with the
AGREE instrument has demonstrated that despite some
increase in quality of guidelines over time, quality scores
have, over the last two decades, remained moderate to
low [19]. Similarly, an evaluation using IoM standards
demonstrated continued poor adherence over the last
two decades, with major deficiencies particularly in the
management of conflicts of interest [18].
In the field of nutrition, previous systematic evalua-
tions show similar methodological limitations [9, 20–22].
Table 1 Institute of Medicine standards for trustworthy
guidelines (2011)
Transparency: details on guideline development and funding are
explicit and publicly accessible
Management of conflicts of interest: prior to finalizing guideline,
panelists being considered for membership should declare all
interests and activities potentially resulting in conflicts, and all
conflicts should be minimized
Guideline group composition is multidisciplinary with methodological
expertise and including patient and community involvement
Use of systematic reviews for guideline questions
Establishing evidence foundations for and rating strength of
recommendations
Clear articulation of recommendations
External review by a full spectrum of stakeholders (e.g. scientific
and clinical experts, patients and community representatives)
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Guidelines issued by several organizations, including au-
thoritative governing bodies, suffer from major limita-
tions in their trustworthiness, relevance and usefulness
for practice [9, 23]. For example, using the AGREE in-
strument, the overall quality of guidelines on nutrition
in critically ill adults is suboptimal, with only four of
nine guidelines being recommended for clinical use [22].
Using AGREE to assess guideline development across 9
guidelines on daily caloric intake from sugar, although
each guideline suggested a decrease in the consumption
of foods and beverages containing sugars, the guidelines
scored poorly on the AGREE criteria, specifically in rigor
of development, applicability, and editorial independence
including conflicts of interest [9].
Not only are conflicts of interest an issue in nutritional
guideline recommendations, but also in systematic reviews
and primary studies [24, 25]. Although underpowered, the
results of systematic reviews on the association between
sugar-sweetened beverages (SSB) and weight gain or obes-
ity appear to be influenced by industry funding. Among
17 identified systematic reviews, for those reviews without
any reported financial conflict of interest, 83.3% (10/12)
of conclusions were that SSB consumption could be a po-
tential risk factor for weight gain. In contrast, the same
percentage of conclusions, 83.3% (5/6) of those reviews
disclosing some financial conflicts with the food and
beverage industry indicated that the scientific evidence
was insufficient to support a positive association between
SSB consumption and weight gain [25]. Further, unique to
the field of nutrition, conflicts related to committed diet-
ary behaviours due to personal, family, religious, social, or
cultural beliefs can impact the interpretation of results
[26]. To optimize the trustworthiness of primary studies,
systematic reviews and guideline recommendations in the
field of nutrition, the importance of efficiently handling
financial, intellectual and other conflicts of interest is
paramount, more so because the nutrition field is highly
polarized, with strong adherents to ideological stances and
evidence of the relationship between financial conflict of
interest and authors’ conclusions [26–28].
Another problem is that nutrition guidelines often
place excessive trust in the results of observational stud-
ies, despite their potentially higher risk of bias [29]. For
instance, consider the evidence from a systematic review
and meta-analysis of cohort studies versus the only RCT
of vitamin C, a micronutrient, for preventing cardiovas-
cular disease. The meta-analysis of nine cohort studies
including over 290,000 patients reported a 25% (95% CI
7 to 40%) relative risk reduction in coronary heart dis-
ease among men consuming supplemental vitamin C
[30]. The Physicians’ Health Study II, a large stand alone
RCT of 14,641 participants, found no reduced risk [31].
In considering a systematic review and meta-analyses of co-
hort studies versus RCTs of antioxidants (i.e. beta-carotene,
vitamin A, vitamin C, vitamin E, selenium), results of early
cohorts studies among people who consumed a diet rich in
these micronutrients demonstrated a lower risk for devel-
oping cardiovascular disease and cancer [32], whereas a
Cochrane systematic review and meta-analysis of 78 RCTs
(n = 296,707) revealed no evidence to support antioxidant
supplements for primary or secondary prevention of
diseases [33]. Over 30 examples of inconsistent results
between cohort studies and RCTs exist [34, 35] dem-
onstrating that, although observational studies have
important roles in identifying issues for subsequent
study and providing guidance prior to the conduct of
definitive investigation, the sole reliance on observa-
tional studies may result in misleading inferences and
recommendations. Systematic reviews of the nutritional
literature should consider observational studies separately
from randomized trials, with the pooled estimates from
the meta-analyses independently assessed for certainty
(quality) of evidence.
The GRADE working group has produced standards
for the evaluation of the certainty of evidence and for
moving from evidence to recommendations that are far
more detailed, explicit, transparent and carefully devel-
oped than prior systems, and are now in use by more
than 100 organizations worldwide [16]. There is evi-
dence that guideline panels making nutritional recom-
mendations are often limited in their experience and
ability to use GRADE methods [9, 36]. For instance, des-
pite the fact that WHO made strong recommendations
to limit the intake of sugar to below 10% of total daily
energy intake, the overall quality of evidence to support
recommendations was low to very low [9]. Similar find-
ings have been observed in a review of guideline recom-
mendations across a variety of health care disciplines
[37]. With exceptions such as acute life-threatening
clinical scenarios (e.g. vitamin K for a patient receiving
warfarin with an intracranial bleed and an elevated INR),
strong recommendations should not be based on low
quality of evidence [15].
Another relevant limitation of many nutrition guide-
lines involves patient or community participation in the
development of recommendations, particularly on the
selection of outcomes deemed important to these partic-
ipants. We systematically identified examples of limited
quality guidelines in nine public health guidelines related
to sugar consumption. As reflected in the domain stake-
holder involvement on the AGREE instrument, many
guidelines did not describe how they sought the views
and preferences of their target population (patients or
the general community), and those that did were vague
about the process [9]. Further, guideline panels omitted
including members of the general community on the
panel, an important component of public health recom-
mendations given the recognition of the importance of
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patient and community oriented research. For instance,
the rationale for the varied sugar intake recommenda-
tions gave undue weight to intermediate outcomes
including nutrient displacement, and weight gain of the
order of 1 kg [9], outcomes not likely of substantial
importance to most patients and community members.
Overcoming the limitations of current nutritional
recommendations
Typically, the many organizations that produce guidelines
are encumbered by institutional constraints and conflicts
of interest, resulting in a profusion of outdated guidelines
that do not adhere to recognized standards [12, 13, 16]. A
potential solution for the limitations of nutrition guide-
lines outlined above is for an independent group with clin-
ical and nutritional content expertise and skilled in the
methodology of systematic reviews and practice guidelines,
but unencumbered by institutional constraints and con-
flicts of interest, to produce trustworthy recommendations.
The BMJ Rapid Recommendations project, an initiative of
MAGIC (Making GRADE the Irresistible Choice), has re-
cently demonstrated the feasibility and utility of this ap-
proach and provided us with the inspiration for
NutriRECS (Nutritional Recommendations and accessible
Evidence summaries Composed of Systematic reviews)
[37]. The NutriRECS working group aims to develop trust-
worthy nutritional recommendations based on internation-
ally accepted methodological standards [12, 13, 16].
Objectives
NutriRECS will develop trustworthy guideline recommen-
dations in nutrition. To do so we will include the applica-
tion of novel and rigorous systematic review and guideline
methods using the GRADE approach to investigate the re-
lationship between diets, foods, nutrients and health out-
comes; integrate patient and community values and
preferences to inform guideline recommendations; apply
strict safeguards against conflicts of interest; and use Evi-
dence to Decision (EtD) frameworks to help people use the
evidence in a structured and transparent way.
Given the extensive number of research questions
and interventions in the broad field of nutrition,
NutriRECS will only have the capacity to focus on a
small number of guideline projects. Selected projects
will be of broad interest to the general public and
previous guideline recommendations produced by mul-
tiple authoritative organizations will have evidence of
extensive methodological limitations (e.g. red and
processed meat).
Methods
GRADE approach
The GRADE (Grading Recommendations, Assessment,
Development and Evaluation) approach is a system for
rating the quality of a body of evidence in systematic re-
views and grading practice guideline recommendations
in health care. GRADE offers a transparent and structured
process for developing and presenting systematic reviews,
and for carrying out the steps involved in developing rec-
ommendations (strong or weak) based on these evidence
reviews [16]. Although the certainty of evidence repre-
sents a continuum, the GRADE approach results in an
assessment of the certainty of a body of evidence into one
of four categories (Table 2).
The strength of a recommendation (strong versus weak)
reflects the extent to which a guideline panel is confident
that adhering to a recommendation will have more desir-
able than undesirable consequences, or vice versa, across
the range of patients, or members of the public, for whom
the recommendation is intended (Table 3). The resulting
recommendations would for instance either recommend
in favor, or against, people reducing their intake of a par-
ticular food or dietary pattern, or, in choosing their diets,
not base their choice of foods on these considerations. If
appropriate, guideline panels may formulate recommen-
dations on specific subgroups of interest (e.g. those with
and without risk factors).
Panel composition and conflict of interest
For each NutriRECS project, panel members will be di-
verse (i.e. patients and community members, nutritional
epidemiologists, research methodologists, primary care
physicians, registered dietitians). As the emphasis of
NutriRECS will be on producing unbiased recommenda-
tions, it will be important to limit conflicts of interest given
that conflicts may be associated with conclusions in sys-
tematic reviews of nutrition [25, 26], and with nutritional
recommendations [9, 21].
Neither the chair nor the methods editor for each
NutriRECS guideline project will have any financial
conflicts of interest. A financial conflict of interest
Table 2 Certainty of evidence
GRADE Definition
High We are very confident that the true effect lies close
to that of the estimate of the effect
Moderate We are moderately confident in the effect estimate:
The true effect is likely to be close to the estimate of
the effect, but there is a possibility that it is substantially
different
Low Our confidence in the effect estimate is limited: The
true effect may be substantially different from the
estimate of the effect
Very Low We have very little confidence in the effect estimate:
The true effect is likely to be substantially different
from the estimate of effect
Although certainty of evidence is a continuum; GRADE’s discrete
categorisation involves some degree of arbitrariness. Nevertheless, advantages
of simplicity, transparency, and vividness outweigh these limitations
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would include the panel member or a family mem-
ber of the panel member having received funds dir-
ectly from a company that produces or promotes a
particular dietary pattern, food, or nutrient. NutriR-
ECS members will also be screened for intellectual
conflicts that include having authored, co-authored,
or held grant funding related to the topic of the
guidelines, or have previously expressed strongly
held beliefs about the guideline topics. We will also
screen potential NutriRECS members for strong per-
sonal or religious beliefs related to the guideline re-
mit. Each panel member will submit a full conflict
of interest form, which will include declarations of
financial, intellectual and other potential conflicts.
We will also closely manage the conflicts of inter-
ests among members of the systematic review team
and the guideline panel team (no member can
have financial conflicts of interest and no more than
one-fourth of members can have intellectual con-
flicts). Up to one third of authors on the systematic
review team can participate on the guideline panel
to help ensure that panellists are fully informed on
the results and nuances of the systematic review.
The methods editor will manage interactions be-
tween systematic review team and the NutriRECS
panel, and submit content to a journal.
Initial NutriRECS research question and evidence of
effects based on systematic reviews
The initial target question for the systematic review to in-
form the first NutriRECS project on red and processed meat
is as follows:
Among adults, what is the impact of dietary patterns
higher in red and processed meat versus diets lower in
red and processed meat intake (replacement with fish,
white meats or vegetarian or vegan diet) on the risk of
outcomes important to patients and community
members (i.e. overall and cardiovascular mortality,
cancer, weight, quality of life, satisfaction with diet,
type II diabetes, and cardiovascular outcomes [fatal
and non-fatal coronary heart disease, non-fatal stroke,
non-fatal myocardial infarction, major adverse cardiac
events (MACE)]) and on factors that may have a
causal relation to cardiovascular outcomes (hyperten-
sion and cholesterol), or other adverse outcomes
(haemoglobin)?
With respect to red and processd meat consumption,
most dietary guidelines suggest limited consumption of
meat because of the reported association with cancer [38–
40]. There is, however, a discrepancy between RCTs and
observational studies on the topic. Although observational
studies tend to show a significant association between red
meat consumption and cancer [41], the Women’s Health
Initiative, one of the largest RCTs conducted assessing
dietary patterns, reported that women consuming a low
fat diet reduced red meat consumption by 20% compared
to controls, yet there was no effect on multiple cancer
types, including colorectal cancer [42, 43]. Despite this,
the WHO has indicated that consumption of red meat is
“probably carcinogenic” to humans while processed meat
is considered carcinogenic to humans [44].
Using the GRADE approach we will begin by working
with our NutriRECS panelists to structure and refine our
health care questions in terms of the population of interest,
and the alternative dietary strategies (e.g. restricted versus
unrestricted dietary patterns) based on the most important
outcomes to the target audience. For all NutriRECS pro-
jects, the target outcomes will be selected based on import-
ance to patients and members of the general community,
and will be elicited prior to our conducting the systematic
reviews of the literature based on discussions with our
NutriRECS panel. Each NutriRECS project panel will have
Table 3 Implications of strong and weak recommendations for different end-users
Implications Strong Recommendation Weak Recommendation
For patients Most individuals in this situation would want the
recommended course of action and only a small
proportion would not.
The majority of individuals in this situation would want
the suggested course of action, but many would not.
For clinicians Most individuals should receive the recommended
course of action. Adherence to this recommendation
according to the guideline could be used as a quality
criterion or performance indicator. Formal decision aids
are not likely to be needed to help individuals make
decisions consistent with their values and preferences.
Recognize that different choices will be appropriate for
different patients, and that you must help each patient
arrive at a management decision consistent with her or
his values and preferences. Decision aids may well be
useful helping individuals making decisions consistent
with their values and preferences. Clinicians should
expect to spend more time with patients when working
towards a decision.
For policy-makers The recommendation can be used to develop policy
(e.g. tax on products high in sugar or salt)
Policy-making will require substantial debates and
involvement of many stakeholders. Policies are also
more likely to vary between regions. Performance
indicators would have to focus on the fact that
adequate deliberation about the management
options has taken place.
Johnston et al. BMC Medical Research Methodology          (2018) 18:162 Page 5 of 11
patients and members of the general community to ensure
selected outcomes are of importance. Unlike dietary guide-
lines we are aware of, we will also work with NutriRECS
panel to identify subgroups of interest (e.g. age, gender,
co-morbidities) and will register the research question and
systematic review protocol, including the subgroups of inter-
est, in PROSPERO (https://www.crd.york.ac.uk/prospero/).
In consultation with an expert librarian, we will con-
duct a systematic search to identify all relevant studies.
We will use data from all eligible studies to generate
independent estimates of the effect from observational
studies and randomized trials, including 95% confidence
interval, for all patient or public important outcomes.
We will ensure the rigor of the review process by follow-
ing Cochrane Handbook guidance, including conducting
duplicate screening of articles, documenting a priori
hypotheses to explain heterogeneity, and conducting
formal assessment of risk of bias in duplicate. Further,
systematic reviews and meta-analyses of observational
studies of food or nutrient intakes (e.g. processed meat),
typically presented by generating relative or absolute dif-
ferences between high consumers (e.g. quantile 5) and
low consumers (e.g. quantile 1) of a target exposure will
be summarized and evaluated seperately from observa-
tional studies that assess dietary patterns (i.e. patterns
that are higher in processed meat, and other patterns of
food consumption). Subsequently, as a novel method, we
will use the summary estimates for each to further ass-
sess etiologic causal inferences. To do so, among out-
comes with a statistically significant effect for a food or
nutrient, if there is also a significant effect (with similar
estimates) based on the dietary pattern data, this will be
seen as evidence that undermines the casual inference
for the target food or nutrient (e.g. processed meat).
After consultation with the NutriRECS panel mem-
bers, our research question, subgroups of interest and
systematic review methods for red and processed meat
and health outcomes has been publically registered with
PROSPERO (ID=CRD42017074074).
Certainty in body of evidence
Subsequently, in duplicate, we will use GRADE methods to
rate the certainty of evidence for each outcome across all
eligible studies according to study design (randomized trials
or observational studies) and five factors that can reduce
certainty of evidence (risk of bias, inconsistency of the re-
sults, indirectness of the evidence, imprecision and publica-
tion bias) and three that can increase certainty (large effect,
dose-response gradient, and direction of plausible con-
founders). The certainty of evidence will reflect our confi-
dence in the estimate of the effect.
Our certainty in the potential desirable and undesirable
effects of the interventions based on the body of evidence
will then be considered in making a recommendation.
Values and preferences of patients and community
members related to diet restrictions and patterns
Optimal nutritional guideline development requires
consideration of patient and community values and
preferences associated with dietary patterns. By values
and preferences we refer to individuals’ predisposition to
either favour (like) or not favour (dislike) something
such as red meat [45]. Modifying dietary intake may be
accompanied by either despondency or pleasure that
affects satisfaction or quality of life. The difficulty many
individuals have modifying their diet attests to their attach-
ment to particular dietary practices. To inform NutriRECS
work based on values and preferences of patients and com-
munity members, we will use the following methods: i)
systematic reviews of the literature addressing values and
preferences related to diet, and ii) inclusion of patient and
public participants on the NutriRECS panel.
We will start by conducting a systematic review of the
literature for evidence regarding peoples’ values and
preferences in regards to red meat.
Moving from evidence to recommendations
For moving from the evidence to recommendations we
will use the Evidence to Decision (EtD) frameworks. The
purpose of Evidence to Decision (EtD) frameworks is to
help people use evidence in a structured and transparent
way to inform decisions in the context of clinical and
public health recommendations. These frameworks
summarize evidence, and its certainty, for benefits,
harms and burdens, values and preferences, cost consid-
erations, as well as equity, acceptability, and feasibility
(Table 4). This approach will ensure that all relevant de-
cisions are transparent to target audiences, thus enabling
decision makers in other jurisdictions to adopt or adapt
our recommendations [46, 47].
The EtD frameworks have a common structure that
includes formulation of the question, an assessment of
the evidence for each criterion, and drawing conclusions.
EtD frameworks make explicit the criteria that are used
to assess interventions or options, the judgments made
by each panel member for each criterion, and the re-
search evidence and additional considerations used to
inform each judgment. Research evidence refers to facts
(actual or asserted) used to inform the panel’s judgments
that are derived from studies that used systematic and
explicit methods. Additional considerations include
other evidence, such as routinely collected data, assump-
tions, and logic used to make a judgment. As a novel
innovation in the field of nutrition guideline develop-
ment, using EtD frameworks we will survey and collect
the anonymous judgements of each panel member prior
to making the recommendations and use these judge-
ments for the purpose of panel discussions prior to mak-
ing the final recommendations. This way, panel
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members who may be afraid to voice dissenting views
during panel meetings will have an opportunity to make
their views known. For instance, panel members may
make different judgments for one or more subgroups
Table 4 Evidence to decision framework
Judgement Research
evidence
Additional
considerations
PROBLEM Is the problem a priority?
○ No
○ Probably no
○ Probably yes
○ Yes
○ Varies
○ Don’t know
DESIRABLE
EFFECTS
How substantial are
the desirable anticipated
effects?
○ Trivial
○ Small
○ Moderate
○ Large
○ Varies
○ Don’t know
UNDESIRABLE
EFFECTS
How substantial are the
undesirable anticipated
effects?
○ Large
○ Moderate
○ Small
○ Trivial
○ Varies
○ Don’t know
CERTAINTY OF
EVIDENCE
What is the overall
certainty of the evidence
of effects?
○ Very low
○ Low
○ Moderate
○ High
○ No included studies
VALUES Is there important
uncertainty about or
variability in how much
people value the main
outcomes?
○ Important uncertainty or
variability
○ Possibly important
uncertainty or variability
○ Probably no important
uncertainty or variability
○ No important uncertainty
or variability
BALANCE OF
EFFECTS
Does the balance between
desirable and undesirable
effects favor the intervention
or the comparison?
○ Favors the comparison
○ Probably favors the
comparison
○ Does not favor either
the intervention or the
comparison
○ Probably favors the
intervention
○ Favors the intervention
○ Varies
○ Don’t know
RESOURCES
REQUIRED
How large are the resource
requirements (costs)?
○ Large costs
Table 4 Evidence to decision framework (Continued)
Judgement Research
evidence
Additional
considerations
○ Moderate costs
○ Negligible costs and
savings
○ Moderate savings
○ Large savings
○ Varies
○ Don’t know
RESOURCES
REQUIRED
What is the certainty of
the evidence
of resource requirements
(costs)?
○ Very low
○ Low
○ Moderate
○ High
○ No included studies
COST
EFFECTIVENESS
Does the cost-effectiveness
of the intervention favor
the intervention or the
comparison?
○ Favors the comparison
○ Probably favors the
comparison
○ Does not favor either
the intervention or the
comparison
○ Probably favors the
intervention
○ Favors the intervention
○ Varies
○ No included studies
EQUITY What would be the impact
on health equity?
○ Reduced
○ Probably reduced
○ Probably no impact
○ Probably increased
○ Increased
○ Varies
○ Don’t know
ACCEPTABILITY Is the intervention acceptable
to key stakeholders?
○ No
○ Probably no
○ Probably yes
○ Yes
○ Varies
○ Don’t know
FEASIBILITY Is the intervention feasible
to implement?
○ No
○ Probably no
○ Probably yes
○ Yes
○ Varies
○ Don’t know
Johnston et al. BMC Medical Research Methodology          (2018) 18:162 Page 7 of 11
(such as patients who are older or who have more severe
disease) in relation to some or all of the criteria.
Afterwards, panels review the judgments they have
made for all of the criteria in their assessment and con-
sider the implications of those judgments for the recom-
mendation or decision. Based on their assessment, the
panel draws conclusions about the strength of recom-
mendation or type of decision; for example, a strong or
weak (sometimes called conditional, discretionary, or
qualified) recommendation for or against an intervention
or option.
Finally, the panel states the recommendation or deci-
sion in a concise, clear and actionable manner, and pro-
vides the justification for their recommendation or
decision. The conclusions also include relevant consider-
ations about subgroups, implementation, monitoring
and evaluation, and research priorities.
NutriRECS oversight and group process
We have formed an international NutriRECS Executive
made up of systematic review and nutrition/public
health experts (Dr. Bradley Johnston, Department of
Community Health and Epidemiology, Dalhousie Uni-
versity, Halifax, Canada; Dr. Malgorzata M. Bala, Chair
of Epidemiology and Preventive Medicine, Department
of Hygiene and Dietetics, Jagiellonian University Medical
College, Cracow, Poland; Cochrane Poland), experts in
guideline methods (Dr. Pablo Alonso-Coello, Iberoamer-
ican Cochrane Centre, Barcelona, Spain; Dr. Gordon
Guyatt, McMaster University, Hamilton, Canada), and a
community member with guideline experience (Ms.
Catherine Marshall, Cochrane Community Representa-
tive, New Zealand). The Executive will determine the
nutrition topics, the systematic review and practice
guideline methods, review and approve conflicts of inter-
est statements and decide whether they are acceptable
and, if acceptable, how they will be managed.
Each NutriRECS question will be addressed by a panel
including a chair, a methods editor, and upwards of 15
additional panel members from around the world. The
chair will be responsible for the management of the
NutriRECS guideline panel meetings, while the methods
editor will be responsible for assembling the panel and
review team, summarizing conflicts of interest for final
assessment by the NutriRECS Executive, and creating
relevant content (e.g. research questions, subgroups of
interest, summary of findings tables based on systematic
reviews, surveys using EtD frameworks, and recommenda-
tions contextualized based on panelists values and prefer-
ences). To produce the systematic reviews, Evidence
Profiles, Evidence to Decision frameworks, and
user-friendly multi-layered presentation formats (interactive
Summary of Findings tables, decision aids), we will use
relevant software that has been developed and user
tested via randomized trials, surveys and consensus
processes [46–50]. Prior to the release of our recom-
mendations we will post the recommendations on our
website (www.nutrirecs.com) and seek feedback from
members of the public.
Dissemination plan
Nutritional guidelines and the supporting systematic
reviews will be widely disseminated via publication in a
high-impact general medicine journal. As well, using
GRADE summary of findings tables and decision aids,
we will produce user-friendly outputs for clinicians, patients
and the community members, including plain language
summaries in multiple languages (e.g. Arabic, Cantonese,
French, Hindi, Mandarin, Polish, Portuguese, Spanish), and
work to ensure these outputs are open-access.
Discussion
Main objectives
NutriRECS and corresponding systematic reviews will
bring together patients and community members as well
as international experts in nutrition and evidence syn-
thesis and translation. Patients, community members
and research experts will have the opportunity to reflect
on the values and preferences of the communities for
which the recommendations are intended in the context
of the summary evidence and arrive at nutritional guide-
line recommendations. Subsequently the guidelines will
be sent for peer-review, and recommendations will be
publically available via open-access publication.
Strengths and limitations
The strength of our proposed methods includes our
commitment to internationally accepted guideline stan-
dards from IoM, GRADE, AGREE and GIN. Our core
NutriRECS group includes leading members of these or-
ganizations, including GRADE and AGREE. Adherence
to these standards will ensure that our recommendations
are based on high quality, novel systematic reviews of
the literature. Our nutritional recommendations will be
put forward by a group of community representatives
and experts in nutrition and epidemiology from around
the world, representatives and experts with limited to no
intellectual or financial conflicts of interest.
Potential limitations of our NutriRECS work include the
current lack of resources to ensure that our recommenda-
tions remain fully accessible around the world to all poten-
tial end-users, including patients and members of the
general community, via multiple platforms, and that our sys-
tematic reviews and nutritional recommendations remain
updated. We are currently seeking funds to regularly update
our NutriRECS work, and to have full access to the MAGIC
authoring and publication platform (www.magicapp.org)
which, based on GRADE evidence summaries, provide
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decision aids to clinicians, patients and the commu-
nity on all electronic devices (e.g. laptops, handheld
devices). Should we be successful with our funding
applications, we will link the scientific journal articles
directly to the content in MAGICapp.
A second limitation is sustained funding for our work.
NutriRECS is made up of a growing international net-
work of investigators and trainees based in four centres
located in Canada (Dalhousie University and McMaster
University), Spain (Iberoamerican Cochrane Centre) and
Poland (Cochrane Poland). Among the four centres, we
have access to an extensive number of local, national,
multi-national grant funding opportunities (e.g. Canadian
Institutes of Health Research, Heart and Stoke Foundation,
Beatrice Hunter Cancer Research Institute, World Cancer
Research Foundation). As with almost all independent
research programs, we do not have permanent funding for
the NutriRECS program. To secure ongoing funding, our
team of investigators and trainees consistently write oper-
ational grants, career grants and trainee grants. We also
sustain ourselves through a large network of research vol-
unteers in exchange for methods training and publication.
A third limitation of our effort is that we have not yet
been in contact with organizations producing nutrition
guidelines to try and forge a collaboration. Our strategy
is to show what can be accomplished in producing trust-
worthy guidelines by an independent group with limited
resources. Having achieved that goal, we believe that this
will place us in a more credible position when interact-
ing with established organizations.
Conclusions
The implications of the NutriRECS project include the
promotion of better-informed decision-making by pa-
tients, members of the community, clinicians, and public
health policy-makers on the desirable and undesirable
effects of alternative dietary patterns, as well as foods
and nutrients on important health outcomes.
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